<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Zelira Therapeutics Ltd — News on 6ix</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd</link>
<description>Latest news and press releases for Zelira Therapeutics Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 02 Mar 2026 03:59:15 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/zelira-therapeutics-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68366a3a78dffbe2df15f6c8.webp</url>
<title>Zelira Therapeutics Ltd</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd</link>
</image>
<item>
<title>Suspension from Quotation</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/suspension-from-quotation-210</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/suspension-from-quotation-210</guid>
<pubDate>Mon, 02 Mar 2026 03:59:15 GMT</pubDate>
<description>Suspension from Quotation</description>
</item>
<item>
<title>Quarterly Activities/Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-128</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/quarterly-activitiesappendix-4c-cash-flow-report-128</guid>
<pubDate>Thu, 29 Jan 2026 03:46:08 GMT</pubDate>
<description>Quarterly Activities/Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>Transformative US$33M Fundraising into Zeliras HOPE 1 SPV</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/transformative-usdollar33m-fundraising-into-zeliras-hope-1-spv</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/transformative-usdollar33m-fundraising-into-zeliras-hope-1-spv</guid>
<pubDate>Fri, 16 Jan 2026 04:24:10 GMT</pubDate>
<description>Transformative US$33M Fundraising into Zeliras HOPE 1 SPV</description>
</item>
<item>
<title>Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-receives-dollar1070000-randd-tax-incentive-scheme-refund</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-receives-dollar1070000-randd-tax-incentive-scheme-refund</guid>
<pubDate>Tue, 25 Nov 2025 08:54:12 GMT</pubDate>
<description>Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund</description>
</item>
<item>
<title>Preliminary Final Report</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/preliminary-final-report-264</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/preliminary-final-report-264</guid>
<pubDate>Fri, 29 Aug 2025 08:21:17 GMT</pubDate>
<description>Preliminary Final Report</description>
</item>
<item>
<title>Zelira Therapeutics Secures R&D Loan Facility</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-therapeutics-secures-randd-loan-facility</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-therapeutics-secures-randd-loan-facility</guid>
<pubDate>Thu, 24 Jul 2025 06:26:04 GMT</pubDate>
<description>Zelira Therapeutics Secures R&D Loan Facility</description>
</item>
<item>
<title>Publication of ZLT-L-007 IRB Approved Observational Study</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/publication-of-zlt-l-007-irb-approved-observational-study</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/publication-of-zlt-l-007-irb-approved-observational-study</guid>
<pubDate>Thu, 22 May 2025 02:42:18 GMT</pubDate>
<description>Publication of ZLT-L-007 IRB Approved Observational Study</description>
</item>
<item>
<title>Zelira secures $1 Million At-the-Market Funding Facility</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-secures-dollar1-million-at-the-market-funding-facility</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-secures-dollar1-million-at-the-market-funding-facility</guid>
<pubDate>Mon, 31 Mar 2025 01:39:37 GMT</pubDate>
<description>Zelira secures $1 Million At-the-Market Funding Facility</description>
</item>
<item>
<title>Appendix 4D & FY25 Interim Financial Report</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/appendix-4d-and-fy25-interim-financial-report-2</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/appendix-4d-and-fy25-interim-financial-report-2</guid>
<pubDate>Wed, 26 Feb 2025 14:35:07 GMT</pubDate>
<description>Appendix 4D & FY25 Interim Financial Report</description>
</item>
<item>
<title>Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-receives-dollar1153000-randd-tax-incentive-scheme-refund</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-receives-dollar1153000-randd-tax-incentive-scheme-refund</guid>
<pubDate>Tue, 18 Feb 2025 07:53:10 GMT</pubDate>
<description>Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund</description>
</item>
<item>
<title>Zeliras HOPE SPV Secures US$681,000 Fourth Funding Tranche</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zeliras-hope-spv-secures-usdollar681000-fourth-funding-tranche</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zeliras-hope-spv-secures-usdollar681000-fourth-funding-tranche</guid>
<pubDate>Tue, 28 Jan 2025 02:46:09 GMT</pubDate>
<description>Zeliras HOPE SPV Secures US$681,000 Fourth Funding Tranche</description>
</item>
<item>
<title>Appendix 4C Cash Flow Report</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/appendix-4c-cash-flow-report-18</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/appendix-4c-cash-flow-report-18</guid>
<pubDate>Tue, 29 Oct 2024 06:00:10 GMT</pubDate>
<description>Appendix 4C Cash Flow Report</description>
</item>
<item>
<title>September 2024 Quarterly Activities Report</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/september-2024-quarterly-activities-report-12</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/september-2024-quarterly-activities-report-12</guid>
<pubDate>Tue, 29 Oct 2024 06:00:10 GMT</pubDate>
<description>September 2024 Quarterly Activities Report</description>
</item>
<item>
<title>Appendix 4E and Financial Report to Shareholders</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/appendix-4e-and-financial-report-to-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/appendix-4e-and-financial-report-to-shareholders</guid>
<pubDate>Wed, 28 Aug 2024 07:56:03 GMT</pubDate>
<description>Appendix 4E and Financial Report to Shareholders</description>
</item>
<item>
<title>June 2024 Quarterly Activities Report</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/june-2024-quarterly-activities-report-14</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/june-2024-quarterly-activities-report-14</guid>
<pubDate>Tue, 30 Jul 2024 03:24:32 GMT</pubDate>
<description>June 2024 Quarterly Activities Report</description>
</item>
<item>
<title>ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zld-advances-hope-autism-drug-program-with-us-fda-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zld-advances-hope-autism-drug-program-with-us-fda-meeting</guid>
<pubDate>Thu, 11 Jul 2024 04:19:28 GMT</pubDate>
<description>ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting</description>
</item>
<item>
<title>ZLD secures US$1.4M unsecured Chairman loan facility</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zld-secures-usdollar14m-unsecured-chairman-loan-facility</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zld-secures-usdollar14m-unsecured-chairman-loan-facility</guid>
<pubDate>Mon, 01 Jul 2024 03:51:15 GMT</pubDate>
<description>ZLD secures US$1.4M unsecured Chairman loan facility</description>
</item>
<item>
<title>HOPE SPV receives US$681,000 third tranche of funding</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/hope-spv-receives-usdollar681000-third-tranche-of-funding</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/hope-spv-receives-usdollar681000-third-tranche-of-funding</guid>
<pubDate>Thu, 23 May 2024 03:11:09 GMT</pubDate>
<description>HOPE SPV receives US$681,000 third tranche of funding</description>
</item>
<item>
<title>March 2024 Quarterly Activities Report</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/march-2024-quarterly-activities-report-14</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/march-2024-quarterly-activities-report-14</guid>
<pubDate>Mon, 29 Apr 2024 11:30:10 GMT</pubDate>
<description>March 2024 Quarterly Activities Report</description>
</item>
<item>
<title>Zelira receives $919,000 R&D Tax Incentive Scheme Refund</title>
<link>https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-receives-dollar919000-randd-tax-incentive-scheme-refund</link>
<guid isPermaLink="true">https://6ix.com/company/zelira-therapeutics-ltd/news/zelira-receives-dollar919000-randd-tax-incentive-scheme-refund</guid>
<pubDate>Mon, 15 Apr 2024 05:37:20 GMT</pubDate>
<description>Zelira receives $919,000 R&D Tax Incentive Scheme Refund</description>
</item>
</channel>
</rss>